These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 27255691)
61. Initial utilization of aflibercept in exudative age-related macular degeneration. Cho H; Weber ML; Shah CP; Heier JS Eur J Ophthalmol; 2014; 24(4):576-81. PubMed ID: 24706352 [TBL] [Abstract][Full Text] [Related]
62. Intravitreal ranibizumab injection for neovascular age-related macular degeneration in phakic versus pseudophakic eyes. Baek JS; Cho HJ; Cho SW; Kim CG; Kim JW Retina; 2013 Mar; 33(3):467-73. PubMed ID: 23400082 [TBL] [Abstract][Full Text] [Related]
64. Effect of Phacoemulsification on Visual Acuity and Macular Morphology in Patients with Wet Age-Related Macular Degeneration. Figurska M; Bogdan-Bandurska A; Rękas M Med Sci Monit; 2018 Sep; 24():6517-6524. PubMed ID: 30220702 [TBL] [Abstract][Full Text] [Related]
65. Response of Pigment Epithelial Detachment to Anti-Vascular Endothelial Growth Factor Treatment in Age-Related Macular Degeneration. Cho HJ; Kim KM; Kim HS; Lee DW; Kim CG; Kim JW Am J Ophthalmol; 2016 Jun; 166():112-119. PubMed ID: 27048998 [TBL] [Abstract][Full Text] [Related]
66. Rate of vision loss in neovascular age-related macular degeneration explored. Real JP; Granero GE; De Santis MO; Juarez CP; Palma SD; Kelly SP; Luna JD Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):1859-65. PubMed ID: 25491161 [TBL] [Abstract][Full Text] [Related]
68. Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration. Schmidt-Erfurth U; Waldstein SM; Deak GG; Kundi M; Simader C Ophthalmology; 2015 Apr; 122(4):822-32. PubMed ID: 25578255 [TBL] [Abstract][Full Text] [Related]
69. THE INFLUENCE OF VITREOMACULAR ADHESION ON OUTCOMES AFTER AFLIBERCEPT THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. McKibbin MA; Suter CA; Willis TA Retina; 2015 Oct; 35(10):1951-6. PubMed ID: 25932561 [TBL] [Abstract][Full Text] [Related]
70. Influence of Vitreomacular Adhesion on Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration. Kanadani TCM; Dos Reis Veloso CE; Dorairaj S; Nehemy MB Ophthalmic Res; 2017; 58(1):18-26. PubMed ID: 28301850 [TBL] [Abstract][Full Text] [Related]
71. Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration. Shin JY; Kwon KY; Byeon SH Acta Ophthalmol; 2015 Sep; 93(6):524-32. PubMed ID: 25581639 [TBL] [Abstract][Full Text] [Related]
72. METAANALYSIS OF REAL-WORLD OUTCOMES OF INTRAVITREAL RANIBIZUMAB FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Kim LN; Mehta H; Barthelmes D; Nguyen V; Gillies MC Retina; 2016 Aug; 36(8):1418-31. PubMed ID: 27388744 [TBL] [Abstract][Full Text] [Related]
73. Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial. Kodjikian L; Souied EH; Mimoun G; Mauget-Faÿsse M; Behar-Cohen F; Decullier E; Huot L; Aulagner G; Ophthalmology; 2013 Nov; 120(11):2300-9. PubMed ID: 23916488 [TBL] [Abstract][Full Text] [Related]
74. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Heier JS; Brown DM; Chong V; Korobelnik JF; Kaiser PK; Nguyen QD; Kirchhof B; Ho A; Ogura Y; Yancopoulos GD; Stahl N; Vitti R; Berliner AJ; Soo Y; Anderesi M; Groetzbach G; Sommerauer B; Sandbrink R; Simader C; Schmidt-Erfurth U; Ophthalmology; 2012 Dec; 119(12):2537-48. PubMed ID: 23084240 [TBL] [Abstract][Full Text] [Related]
75. Comparison of Eylea® with Lucentis® as first-line therapy in patients with treatment-naïve neovascular age-related macular degeneration in real-life clinical practice: retrospective case-series analysis. Böhni SC; Bittner M; Howell JP; Bachmann LM; Faes L; Schmid MK BMC Ophthalmol; 2015 Aug; 15():109. PubMed ID: 26289356 [TBL] [Abstract][Full Text] [Related]
76. Comparison of intravitreal ranibizumab in phakic and pseudophakic neovascular age-related macular degeneration patients with good baseline visual acuity. Ozkaya A; Alkin Z; Yazici AT; Demirok A Retina; 2014 May; 34(5):853-9. PubMed ID: 24141904 [TBL] [Abstract][Full Text] [Related]
77. Morphology and Visual Acuity in Aflibercept and Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration in the VIEW Trials. Waldstein SM; Simader C; Staurenghi G; Chong NV; Mitchell P; Jaffe GJ; Lu C; Katz TA; Schmidt-Erfurth U Ophthalmology; 2016 Jul; 123(7):1521-9. PubMed ID: 27157149 [TBL] [Abstract][Full Text] [Related]